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Mutations in methyl-CpG-binding protein 2 (MECP2) gene have been shown to manifest
in a neurodevelopmental disorder that is called Rett syndrome. A typical problem that
occurs during development is a disturbance of breathing. To address the role of inhibitory
neurons, we generated a mouse line that restores MECP2 in inhibitory neurons in the
brainstem by crossbreeding a mouse line that expresses the Cre-recombinase (Cre) in
inhibitory neurons under the control of the glycine transporter 2 (GlyT2, slc6a5) promotor
(GlyT2-Cre) with a mouse line that has a floxed-stop mutation of the Mecp2 gene
(Mecp2stop/y). Unrestrained whole-body-plethysmography at postnatal day P60 revealed
a low respiratory rate and prolonged respiratory pauses inMecp2stop/y mice. In contrast,
GlyT2-Cre positive Mecp2stop/y mice (Cre+; Mecp2stop/y) showed greatly improved
respiration and were indistinguishable from wild type littermates. These data support
the concept that alterations in inhibitory neurons are important for the development of
the respiratory phenotype in Rett syndrome.
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INTRODUCTION
The neurodevelopmental disorder Rett syndrome (OMIM 312750, Rett, 1966) is caused by
mutations in the gene for the methyl-CpG-binding protein 2 (MECP2). Although MECP2 is a
X-chromosomal gene, Rett syndrome usually describes the phenotype of girls with a heterozygous
mutation that occurs at a prevalence of 1/10,000–1/15,000 female births. Rett syndrome is often
inherited from maternal and paternal de novo germline mutations (Thomas, 1996; Girard et al.,
2001) but also can be transmitted through generations if the X-chromosomal inactivation of
the maternal mutation is skewed (Hoffbuhr et al., 2001). After a latent period of approximately
1–3 years (Rett, 1966) girls develop a neurological phenotype that includes stereotypic hand
movements, seizures, and typically also autonomic dysfunctions with breathing abnormalities as
well as mental retardation with loss of language skills (Jellinger, 2003). The clinical spectrum in
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boys with MECP2-mutations is more diverse, ranging from a
classic form of the Rett syndrome (Masuyama et al., 2005) to
severe cases of neonatal encephalopathy (Villard, 2007; Reichow
et al., 2015).
Alterations of breathing are observed both in male and female
patients with MECP2-mutations. The respiratory phenotype of
female Rett syndrome patients is characterized by periods of
hyperventilation alternating with prolonged periods of breath-
holdings causing intermittent hypoxia (Julu et al., 2001), which
often resemble apneustic breathing (Kerr and Julu, 1999). These
disturbances of breathing are discussed as a main cause of
sudden death (Kerr et al., 1997). In contrast, the male phenotype
often exhibits respiratory insufficiency soon after birth with
hypoventilation and prolonged apneas (Geerdink et al., 2002;
Kankirawatana et al., 2006; Schüle et al., 2008).
There are many different mouse models available that
resemble symptoms of the classical Rett syndrome (Ricceri et al.,
2008). The male Mecp2−/y null mouse is often used as a model
(Guy et al., 2001) since it shows impaired locomotion including
hind limb clasping and autonomic dysfunctions with respiratory
abnormalities. However, it becomes evident that the typical
alteration of breathing in male MECP2-deficient mice is rather
hypoventilation that presents with a reduced respiratory rate
and minute ventilation together with a high number of apneas
(Viemari et al., 2005; Chao et al., 2010; Vogelgesang, 2013;
Wegener et al., 2014), but not apneustic breathing (Stettner et al.,
2007). These observations suggest that male MECP2-deficient
mice might be a good model for breathing phenotype of male
patients.
Nevertheless, both data from male MECP2-deficient mice
and heterozygous female mice point toward alterations in
inhibitory neurons that are involved in disease progression. For
example, a knockout of the Mecp2 gene in inhibitory neurons,
using a VIAAT-specific expression of the Cre-recombinase, has
been shown to be sufficient for the generation of respiratory
phenotype (Chao et al., 1997). Although VIAAT is known
to be expressed both in GABAergic as well as in glycinergic
neurons (Chaudhry et al., 1998), the phenotype of the VIAAT-
Cre induced Mecp2-KO was attributed to the loss of MECP2
in GABAergic neurons (Chao et al., 1997). Early changes of
inhibitory synaptic transmission that are observed in Mecp2−/y
mice at P7 were also effecting the GABAergic system (Medrihan
et al., 2008). Since GABA/glycine co-transmission is common at
P7 in the respiratory system (Rahman et al., 2013) and VIAAT-
levels in Mecp2−/y mice were also reduced (Medrihan et al.,
2008), we assume that alteration of synaptic inhibition is one
of the key failures during early development. We therefore
can hypothesize that breathing can be improved if MECP2 is
introduced inhibitory neurons of the respiratory network.
The current experiments were designed to test if the
breathing and/or the developmental progression of the disease
is significantly improved by preventing the loss of MECP2 in
inhibitory neurons of the brainstem and spinal cord, which are
involved in the regulation of breathing (Richter and Smith, 2014).
To achieve this goal we used a mouse line allowing expression of
the Cre-recombinase in inhibitory neurons under control of the
GlyT2-promotor (Ishihara et al., 2010; Rahman et al., 2015) that
was crossbred to a global knock-out of Mecp2, which has been
achieved by a knock-in of a loxP-site flanked stop codon into the
locus of theMecp2 gene (Mecp2Stop/y mice; Guy et al., 2007). We
focused on changes of breathing, that are typically observed in
the male mouse models of the Rett syndrome, regardless whether
Mecp2 is knocked out in all cells (Guy et al., 2001) or only in
inhibitory neurons (Chao et al., 2010).
METHODS
Animals and Genotyping
Animals were bred in the central animal facility of the University
medical center of the Georg-August University Göttingen and
treated in accordance with the German Protection of Animals
Act (TierSchG) and with the guidelines for the welfare of
experimental animals issued by the European Communities
Council Directive 2010/63/EU. The file number of the Lower
Saxony authorities (Nds. Landesamt für Verbraucherschutz
und Lebensmittelsicherheit, LAVES) is 33.9-42502-04-15/1764.
Heterozygous female founder mice (B6.129P2-Mecp2tm2Bird/J;
Mecp2stop/x) were ordered from The Jackson Laboratory (Stock
Number: 006849).GlyT2-Cre (Tg(Slc6a5-iCre)121Veul) mice were
originally provided by Volker Eulenburg (Erlangen). Mating was
always made from Mecp2stop/x heterozygous female (Guy et al.,
2007) and GlyT2-Cre positive male mice (Ishihara et al., 2010).
Both lines were maintained on a C57/B6 background. After birth
all offspring were raised by foster mice.
Genotyping was performed using standard PCR technique
described in the original publication of the GlyT2-Cre mice




Mice were deeply anesthetized using isoflurane (1-Chloro-
2,2,2-trifluoroethyl-difluoromethylether, Abbott, Germany) and
perfused transcardially using 4% paraformaldehyde (PFA) in
phosphate buffered saline (PBS). Brains were removed and post-
fixed in 4% PFA in PBS for 24 h and stored in PBS until
used for sectioning. Before sectioning, brains were equilibrated
in HEPES buffer (7.5 g NaCl, 0.3 g KCl, 0.06 g KH2PO4, 0.13 g
Na2HPO4, 2 g Glucose, 2.4 ml 10mM HEPES, 0.1 g MgCl2,
0.05 g MgSO4, 0.165 g CaCl2, pH 7.4) for 48 h, cryoprotected
in 15% sucrose in PBS for 24 h followed by equilibration in
30% sucrose in PBS for 24 h at 4◦C, and then frozen at −80◦C.
Series of 30-µm-thick brain sections ranging from cervical
spinal cord to midbrain colliculi were cut using a freezing
microtome (Frigocut, Reichert-Jung). Sections were stored in
HEPES buffer. All buffers were supplemented with small amount
sodium azide (NaN3). Antigen retrieval was performed in citrate
buffer (10 mM citric acid, 0.05% Tween20, pH 6.0) at 80◦C
for 30 min. Sections were incubated in blocking buffer (PBS,
0.1% Triton-X100, 1% Tryptone/Peptone) for 60min at RT to
permeabilize and block non-specific binding. Primary antibody
(rabbit anti-MECP2, Cell signaling, cat. No. 3456S) was diluted
1:400 in blocking buffer and incubated for 60 min at RT. After
rinsing in buffer (PBS, 0.05% Tween20, 0.3% Triton X100),
sections were incubated for 1 h at RT in the dark with anti-rabbit
atto647-conjugated secondary antibodies (Sigma-Aldrich, Cat.
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No. 40839) diluted 1: 400 in blocking buffer. During washing,
sections were counterstained with DAPI and mounted onto
microscope-slides and coverslipped with fluorescent mounting
medium (DAKO). Immunofluorescence was analyzed with an
Axio Imager.Z1 fluorescence microscope (Zeiss) equipped with
a mercury vapor short-arc lamp (HBO100, Zeiss), filters for
DAPI (Ex. 335–383 nm, Bs. 395 nm, Em. 420–470 nm) and
Cy5 (Ex. 625–655 nm, Bs. 660 nm, Em. 665–715 nm) and a
digital camera (AxioCam MRm, Zeiss). Images were taken at
10x magnification with Zeiss Zen2 software and imported into
FIJI/ImageJ, digitally adjusted if necessary for brightness and
contrast, and assembled into plates using CorelDraw Software.
Composite pictures were generated by the Microsoft image




To determine parameters of ventilation we used unrestrained
whole-body-plethysmography. Mice were placed in an acrylic
glass chamber that was connected to a differential low-pressure
TRD5700 Pressure Transducer (Buxco). The second channel of
the pressure transducer was connected to a reference chamber
that was connected to room air through a fine-mesh screen.
Warming of the inspired air and cooling during expiration
results in pressure changes (Drorbaugh and Fenn, 1955; Bartlett
and Tenney, 1970). Since the chamber allows air to pass in
and out through a defined resistor (a fine-mesh screen) the
pressure changes in the chamber represent air flow (principle
of a screen pneumotach). The leak in the chamber introduced
a time constant for the decay of pressure changes of 40 ms.
A negative pressure bias flow of 1 l/min was introduced by
a small animal bias flow generator (DSI). The bias flow was
also used to calibrate the chamber. Data were acquired using
a PC-computer running Ponemah software (DSI). Flow signals
were exported to ASCII and imported to LabChart software
(ADInstruments), band-pass filtered (0.5–20Hz) oﬄine. Mice
were allowed to explore the chamber for 12 min to adapt
to the new environment before the measurement was started.
For analysis of respiratory cycle length (inspiratory peak to
peak interval) a period of 3 min was analyzed by the peak
analysis module of LabChat software. Breathing frequencies were
calculated as the reciprocal of the averaged inspiratory interval.
Peak to peak intervals that were longer than 1 s (0.75 s) were
counted during the 3 min period and were referred to as number
of apneas >1 s/3 min (>0.75 s/3 min). The coefficient of variation
(CV) of the cycle period (inspiratory interval) and the irregularity
score (IS = 100 ∗ ABS[(Intn − Intn−1)/Intn−1]) of the interval
were calculated to assess variability of breathing (Wegener et al.,
2014).
When the mice were transferred from the plethysmography
chamber back to the cage, they were grasped by the tail and
kept in air for up to 20 s to test for hind limb clasping. Hind
TABLE 1 | Summary of detected changes in Mecp2-KO and GlyT2-MECP2.
WT CTRL Mecp2-KO GlyT2-MECP2
GENOTYPE
Mecp2 +/y +/y stop/y stop/y
GlyT2-Cre (BAC) neg. pos. neg. pos.
AGE (P40; < P55) 41.3 ± 3.2 40.9 ± 1.9 43.1 ± 4.7 41.4 ± 2.6
Number 10 19 9 14
BW (g)A 19.1 ± 2.7 20.4 ± 1.4 16.2 ± 2.3# 18.0 ± 2.9
HLC [%]χ2 0 0 16.7 0
BPMA 405.9 ± 39.8 372.2 ± 78.9 354.2 ± 81.0 320.6 ± 80.0
Apnea (>1 s)/3 minAR 0.4 ± 0.8 0.5 ± 1.3 7.0 ± 11.3# 2.0 ± 2.1
Apnea (>750 ms)/3 minAR 1.5 ± 1.6 1.5 ± 3.0 12.6 ± 14.5*,# 5.1 ± 4.6
CV cycle periodAR 0.54 ± 0.11 0.50 ± 0.09 0.78 ± 0.27# 0.58 ± 0.19
IrrScore cycle periodAR 0.34 ± 0.06 0.33 ± 0.06 0.48 ± 0.12*,# 0.36 ± 0.14
AGE (P60; P55-P70) 62.8 ± 4.4 63.6 ± 3.1 61.7 ± 3.0 60.6 ± 2.3
Number 9 16 11 10
BW (g)AR 24.0 ± 2.3 26.1 ± 1.8 21.3 ± 6.1# 24.4 ± 1.4
HLC [%]χ2 0 0 44.4*±# 0
BPMA 388.6 ± 54.7 394.4 ± 60.8 292.5 ± 104.7*,# 372.8 ± 68.0
Apnea (>1 s)/3 minAR 1.2 ± 2.4 0.3 ± 0.8 6.7 ± 6.8# 0.9 ± 1.5
Apnea (>750 ms)/3 minAR 2.7 ± 4.8 2.0 ± 2.3 14.1 ± 16.1*,# 3.2 ± 4.0
CV cycle periodA 0.53 ± 0.15 0.51 ± 0.09 0.64 ± 0.16 0.57 ± 0.10
IrrScore cycle periodAR 0.33 ± 0.06 0.33 ± 0.05 0.39 ± 0.11 0.37 ± 0.06
Significant differences (p < 0.05 from the multiple comparison procedures) are indicated with asterisks (compared to WT) or octothorpes (compared to CTRL). Hind limb clasping
(HLC) is given as the % of animals showing this symptom. Coefficient of variation (CV) and irregularity score (IrrScore) were calculated from the cycle periods. The type of test that was
performed is indicated in the first column: χ2Chi-square; AANOVA; ARANOVA on ranks. Data are given as mean ± standard deviation (SD).
Frontiers in Physiology | www.frontiersin.org 3 September 2016 | Volume 7 | Article 385
Hülsmann et al. MECP2-Expression in Hindbrain Inhibitory Neurons
FIGURE 1 | (A,B) Low magnification tiled images from the medulla (A) and forebrain (B) showing successful rescue of MECP2-expression in the brainstem of
Mecp2Stop/y mice using GlyT2-Cre in the brainstem of a Cre+; Mecp2Stop/y mouse. (C–E) Image detail from (A) confirming the expression of MECP2 in the
ventrolateral medulla (VLM). IO: inferior olive. (F–H) In the Cortex (CX) and Hippocampus (CA) only spurious expression of MECP2 is observed (G). In panel (E,H),
DAPI staining is shown in blue, and MECP2/atto647 fluorescence is shown in red.
limbs clasping (HLC) was noted if both hind limbs were retracted
toward the abdomen. The numeric values (shown in Table 1) are
% of animals showing HLC. The operator was not blinded to the
genotype.
Statistical Analysis
All tests were performed on a Microsoft Windows 10 PC
using SigmaPlot (version 12.5; Systat Software GmbH).
Analysis of variance (one way ANOVA) with all pairwise
multiple comparison procedures (Holm–Sidak method) was
used. ANOVA on ranks (Kruskal–Wallis) was used with
an all pairwise multiple comparison procedures (Dunn’s
method), if the normality test (Shapiro–Wilk) failed. Motor
phenotype was compared using a Chi-square test. The
Kaplan–Meier estimator was used for survival analysis.
For statistical comparison of survival, the Gehan–Breslowl
test was used. Data are presented as mean ± standard
deviation (SD).
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FIGURE 2 | (A) Unrestrained whole-body plethysmography recordings from WT (black), Control mice (GlyT2-Cre; blue), MECP2-deficient Mecp2stop/y mice (red) and
mice, in which MECP2 was expressed in GlyT2-Cre positive neurons (Mecp2stop/y, Cre+; green). Trace show arbitrary unit (a.u.) of the flow. Inspiration is upward,
expiratory flow is downward going. (B,C) Statistical analysis of the respiratory rate in breaths per minute (BPM; B) and the number of apneas that were larger than 1 s
(C). In the box plots the boundary of the box closest to zero indicates the 25th percentile, the solid lines within the box marks the median (the dotted lines are mean),
and the boundary of the box farthest from zero indicates the 75th percentile. Whiskers (error bars) above and below the box indicate the 90th and 10th percentiles.
Asterisks represent statistical significance (p < 0.05).
RESULTS
Immunostaining for MECP2 Expression in
Hindbrain
In a first set of experiments we tested if excision of the
stop-cassette in Mecp2stop/y mice by the expression of Cre-
recombinase using GlyT2-Cre mice was effective to allow
expression of MECP2 in hindbrain neurons. As shown in
Figure 1, MECP2 expression was preserved in a subset of
brainstem neurons of Mecp2stop/y GlyT2-Cre positive mice.
Notably only a few neurons expressed MECP2 in the cortex and
hippocampus.
Respiratory Phenotype Is Diminished If
MECP2-Expression Is Preserved in
GlyT2-Cre Mice
Mice were functionally analyzed in two groups (Table 1). The
first group was tested at ∼6 week (P40), when Mecp2stop/y mice
were reported to develop first symptoms (Guy et al., 2007). At this
earlier stage we did not observe any difference in the respiratory
rate nor in the number of apneas, that are a typical problem of
the phenotype (Wegener et al., 2014). Also no significant change
in the motor system was observed and only one Mecp2stop/y
mouse at this age showed hind limb clasping (Table 1). At
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P40 the breathing frequency of freely moving WT mice was
405.9 ± 39.8 breaths per minute (BPM; mean ± SD) in control
(Cre+; Mecp2+/y) mice 372.2 ± 78.9 BPM was recorded. At this
early stage,Mecp2stop/y mice were indistinguishable from control
mice. They had a breathing rate of 354.2± 81.0 BPM (P= 0.050),
while inmice, in which the stop-codonwas removed in inhibitory
neurons (Cre+;Mecp2stop/y), the rate was 320.6± 80.0 BPM.
At P60 a significant change in the breathing was observed in
Mecp2stop/y mice (Figure 2).WhileWTmice (388.7± 54.7 BPM)
and control mice (394.4± 60.8 BPM) showed a regular breathing,
Mecp2stop/y mice had only 292.5± 104.7 BPM (p= 0.030 vs. WT
mice, p = 0.006 vs. control mice). In contrast, the breathing rate
of mice in which theMECP2 was restored in hindbrain inhibitory
neurons (cre+;Mecp2stop/y) was indistinguishable from WT and
control littermates (372.8 ± 68.0 BPM; p = 0.873 vs. WT and
p = 0.851 vs. control mice). A significant number of pauses
that were longer than 1 s was only observed in Mecp2stop/y
GlyT2-Cre negative mice (Figure 2; Table 1). Although the
motor phenotype was not completely developed at P60, hind
limb clasping was observed only in 44.4% of Mecp2stop/y mice
but neither in control and WT mice nor GlyT2-Cre positive
Mecp2stop/y mice (Table 1).
Survival Is Not Improved
Although we observed a significant improvement of breathing
at ages MECP2-deficient mice start to deteriorate, we did not
find an improvement of the overall survival in GlyT2-Cre
positiveMecp2stop/y mice (Figure 3), indicating that the obvious
improvement of breathing is not preventing a further progression
of the disease.
DISCUSSION
Our data support the concept that a MECP2-deficiency in
inhibitory neurons is a key factor in generation of the
FIGURE 3 | Kaplan–Meier plot of survival for control mice (GlyT2-Cre;
blue), MECP2-deficient Mecp2stop/y mice (red) and mice, in which
MECP2 was expressed in GlyT2-Cre positive neurons (Cre+;
Mecp2stop/y, green).
breathing phenotype in male MECP2-deficient mice. An early
reintroduction of MECP2 in neurons, which express the glycine
transporter 2, improves ventilation and eliminates prolonged
periods of apnea, which both are the typical signs in male
MECP2-deficient mice in vivo (Viemari et al., 2005; Chao et al.,
2010; Wegener et al., 2014). This observation is in line with
the results from a conditional Mecp2 knock out in GABAergic
neurons (Chao et al., 2010). Although the respiratory phenotype
was observed to start rather late in the VIAAT-Cre mediated
model—the data shown by Chao and colleagues were from
postnatal week 32—the observed changes are typical for male
MECP2-deficient mice (Chao et al., 2010).
In our hands,Mecp2stop/y mice developed first signs of altered
breathing after P40 and hypoventilation became significantly
different to control mice around P60. When the stop-codon
was deleted by the Cre-recombinase in GlyT2-Cre positive
neurons the development of this typical change in breathing
were alleviated (Figure 2) indicating that expression of MECP2
in hindbrain inhibitory neurons is sufficient for preventing the
development of the respiratory phenotype. We assume that this
rescue occurs in both type of inhibitory neurons in the respiratory
network, since during embryonic development, GlyT2-Cre is
expressed not only in glycinergic neurons (Gomeza et al., 2003b)
but also in GABAergic neurons (Rahman et al., 2015). Additional
experiments are required to distinguish between the role of
GABAergic and glycinergic neurons.
However, reasonable evidence points toward disturbances
in the GABAergic system. At first, 7 day old male MECP2-
deficient mice show early changes in GABAA-receptor expression
and postsynaptic GABA currents in the pre-Bötzinger Complex
(Medrihan et al., 2008). Furthermore, substantial changes in
GABAergic transmission in the Kölliker–Fuse region of the pons
have been reported to contribute to the breathing phenotype in
adult heterozygous females (Abdala et al., 2016). On the other
hand, pharmacological improvements of breathing phenotype
can also be attributed to an improvement of GABAergic
transmission (Abdala et al., 2010; Voituron and Hilaire, 2011;
Bittolo et al., 2016). Moreover, it is reasonable to assume that
any change of GABAergic transmission that affects breathing
is located in the hindbrain since neither the conditional Mecp2
knock out in Parvalbumin-positive neurons (He et al., 2014; Ito-
Ishida et al., 2015) nor in Somatostatin-positive neurons (Ito-
Ishida et al., 2015) were able to mimic the breathing phenotype
of the conditional VIAAT-dependent (Chao et al., 2010) or
constitutionalMecp2 knock out in vivo (Viemari et al., 2005).
We cannot exclude that the repression of MECP2 in
GlyT2-Cre positive inhibitory neurons, which is supposed
to start during embryonic development, is just delaying the
onset of the respiratory phenotype by improving inhibitory
neurotransmission without affecting the disturbance in
glutamatergic neurons or glial cells. It was recently shown
(Garg et al., 2015) that restoration of MECP2 in glutamatergic
(Vglut-cre+/−) neurons significantly improved premature
lethally of male MECP2-deficient mice (Mecp2stop/y). Although
no information is giving regarding the respiratory phenotype in
that publication, their data favor a role of glutamatergic neurons
in the disease progression. Interestingly, restoration of MECP2 in
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astrocytes also improved both breathing and lifespan (Lioy et al.,
2011). We can only speculate whether re-expression of MECP2
in astrocytes improved the breathing by effecting transport of the
inhibitory neurotransmitters (Gomeza et al., 2003a; Szoke et al.,
2006) and excitatory neurotransmitters (Schnell et al., 2011) or
whether other factors unrelated to synaptic transmission in the
respiratory network are important.
Outlook
It has been suggested that hypoxia in younger MECP2-deficient
mice and the resulting oxidative stress is an important factor
for the progression and pathogenesis of Rett syndrome (De
Felice et al., 2009, 2012). However, our data shine new light
on this concept. Although breathing disturbances are strongly
improved or at least delayed when MECP2 is preserved in
inhibitory neurons, no prolongation of the life span was
observed, suggesting that not the respiratory network failure but
rather the loss of MECP2 in other brain region and especially
in excitatory neurons is promoting the overall deterioration of
MECP2-deficent mice.
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